CorrlensCorrlens
Correlate

Correlation Analysis

Eli Lilly & Co. vs Sempra

LLY vs SRE

+0.576

Moderate positive

When one moves up, the other tends to follow.

LLY logo

Eli Lilly & Co.

LLY

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Market cap 828.2B · 50,000 employees

SRE logo

Sempra

SRE

Sempra Energy serves one of the largest utility customer bases in the United States. It distributes natural gas and electricity in Southern California and owns 80% of Oncor, a transmission and distribution business in Texas. Sempra Infrastructure partners, of which Sempra will hold a 25% ownership, owns and operates liquefied natural gas facilities in North America and infrastructure in Mexico.

Market cap 64B · 15,938 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockHealthcare

Time Series

Relative Performance

Green: LLYGray: SRE36 of 1,254 points (sampled)

Who Moves First

in sync

LLY and SRE tend to move at the same time.

After testing 13 timing shifts, the strongest relationship was +0.576 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

+0.687

13 periods · Return correlation when both series rose

Both Falling

N/A

2 periods · Return correlation when both series fell

Diverging

-0.546

20 periods · Return correlation when series moved apart

R-Squared

33.2%

Share of variance in one series explained by the other.

Trend Agreement

54.9%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [0.538, 0.612]

Scatter

XY Regression

1142004006008001,0001,14261.7708090100101.2Eli Lilly & Co.SempraData pointsFit (r = 0.576)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

LLY logo

Eli Lilly & Co.

LLY

Market cap 828.2B · 50,000 employees

Stock · 1,254 raw → 1,254 prepared

Series B

SRE logo

Sempra

SRE

Market cap 64B · 15,938 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

7

Estimated crossover points between normalized spreads.

Slope

0.0173

Linear regression slope.

Intercept

66.8807

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 7 hours ago · ID: stock-lly-vs-stock-sre-daily